Submitted:
28 January 2021
Posted:
29 January 2021
You are already at the latest version
Abstract
There is now considerable evidence that several infectious agents (viruses, bacteria, or parasites) may play a contributing role in the development of Alzheimer’s disease (AD). The six primary suspects are herpes viruses, spirochetal bacteria, Chlamydia pneumoniae, Porphyromonas gingivalis, mycobacteria, and toxoplasma parasites. Also, some of the antimicrobial and antiviral agents that are used to treat them have shown promise for AD interventions. I describe this evidence and assert it is now time to accelerate clinical trials of these existing drugs, already federally approved, to determine if such treatments can delay, halt, or reverse AD.
Keywords:
Alzheimer’s disease
; dementia
; beta-amyloid
; germ theory
; drug development
; clinical trials
; herpes
; spirochetes
; Chlamydia pneumoniae
; Porphyromonas gingivalis
; toxoplasma
; mycobacteria
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
